other material
confidence high
sentiment neutral
materiality 0.65
Cardiff Oncology raises ~$10M in registered direct offering of common stock and warrants
Cardiff Oncology, Inc.
- Sold 8,571,429 shares at $1.05/share with warrants for 8,571,429 shares at $1.31 exercise price.
- Insiders purchased 731,707 shares at $1.435/share with warrants; total gross proceeds ~$10M.
- Warrants exercisable after six months and authorized share increase; expire 5.5 years from start.
- Net proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; closing expected July 16, 2026.